Literature DB >> 28969206

Coronary Endarterectomy: Recent Trends.

Ravi Ghatanatti1, Anita Teli2.   

Abstract

Coronary Endarterectomy (CE) assures complete revascularization of the myocardium in case of diffusely diseased vessels and prevents residual ischemia. Recently cardiac surgeons are performing increasing number of coronary endarterectomy and it has evolved as an important adjuvant procedure in Coronary Artery Bypass Grafting (CABG). There are controversies regarding the efficiency of CE. CE is criticised for its higher rates of morbidity and mortality. At present the available evidence supports CE in Off Pump Coronary Artery Bypass surgery (OPCAB) and along with valvular procedures. Graft patency is better with open technique. Postoperative anticoagulation regimen though not uniform, the overall outcome remains the same. Therefore, it is important to focus on the current results to accept CE as a routine procedure like CABG.

Entities:  

Keywords:  Anticoagulation regimen; Conduit patency; Coronary artery bypass grafting; Coronary revascularization

Year:  2017        PMID: 28969206      PMCID: PMC5620847          DOI: 10.7860/JCDR/2017/27036.10339

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  30 in total

1.  Improved clinical outcomes in patients undergoing coronary artery bypass grafting with coronary endarterectomy.

Authors:  O M Shapira; G Akopian; A Hussain; M Adelstein; H L Lazar; G S Aldea; R J Shemin
Journal:  Ann Thorac Surg       Date:  1999-12       Impact factor: 4.330

2.  Survival after coronary endarterectomy in man.

Authors:  C P BAILEY; A MAY; W M LEMMON
Journal:  J Am Med Assoc       Date:  1957-06-08

3.  Left anterior descending coronary endarterectomy: early and late results in 196 consecutive patients.

Authors:  John G Byrne; Alexandros N Karavas; Tomas Gudbjartson; Marzia Leacche; James D Rawn; Gregory S Couper; Robert J Rizzo; Lawrence H Cohn; Sary F Aranki
Journal:  Ann Thorac Surg       Date:  2004-09       Impact factor: 4.330

4.  Extensive endarterectomy and reconstruction of the left anterior descending artery: early and late outcomes.

Authors:  Patrick O Myers; Minoru Tabata; Prem S Shekar; Gregory S Couper; Zain I Khalpey; Sary F Aranki
Journal:  J Thorac Cardiovasc Surg       Date:  2012-04-13       Impact factor: 5.209

5.  Optimal method of coronary endarterectomy for diffusely diseased coronary arteries.

Authors:  Hiroyuki Nishi; Satoru Miyamoto; Shuichiro Takanashi; Hirokazu Minamimura; Takumi Ishikawa; Yasuyuki Kato; Yoshihiro Shimizu
Journal:  Ann Thorac Surg       Date:  2005-03       Impact factor: 4.330

Review 6.  Inflammatory response to cardiopulmonary bypass.

Authors:  L H Edmunds
Journal:  Ann Thorac Surg       Date:  1998-11       Impact factor: 4.330

7.  Reappraisal of coronary endarterectomy for the treatment of diffuse coronary artery disease.

Authors:  T M Sundt; C J Camillo; E N Mendeloff; H B Barner; W A Gay
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

8.  The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease.

Authors:  G M Lawrie; G C Morris; A Silvers; W F Wagner; A E Baron; S S Beltangady; D H Glaeser; D W Chapman
Journal:  Circulation       Date:  1982-10       Impact factor: 29.690

9.  Results of coronary artery endarterectomy and coronary artery bypass grafting for diffuse coronary artery disease.

Authors:  Srikrishna Sirivella; Isaac Gielchinsky; Victor Parsonnet
Journal:  Ann Thorac Surg       Date:  2005-11       Impact factor: 4.330

10.  The impact of coronary artery endarterectomy on outcomes during coronary artery bypass grafting.

Authors:  Damien J LaPar; Farshad Anvari; James N Irvine; John A Kern; Brian R Swenson; Irving L Kron; Gorav Ailawadi
Journal:  J Card Surg       Date:  2011-04-07       Impact factor: 1.620

View more
  1 in total

1.  Computed Tomography-Based Angiographic Evaluation of Graft Patency Rate After Coronary Artery Bypass Graft Surgery in Bangladesh.

Authors:  Redoy Ranjan; Kevin Matthew Sales; Asit Baran Adhikary
Journal:  Cureus       Date:  2022-09-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.